CellaVision AB, which develops and sells image based products for routine analysis of blood, has appointed Johan Wennerholm new CFO, starting on the 1st of July, 2007.
Johan Wennerholm will take overall responsibility for the Group's Finance and Administration function and will be part of the management team. Johan Wennerholm, 39 years old, holds a degree in economics and business administration, and has several years of experience with growing technology companies and relations to the capital market. He most recently held the position as CFO of Nextlink AB, listed on First North at the OMX Stockholm Stock Exchange, and has earlier held Finance and Administration positions with the Doro Group and the Tetra Pak Group.
CellaVision AB develops, markets, and sells the market leading image analysis based systems for routine analysis of blood. The company has a core competence in development of software and hardware for automatic image analysis of cells and cell changes for applications in health and medical care. The company develops and markets systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials. The company's associates have expertise in advanced imaging analysis, artificial intelligence, and automated microscopy.
The company headquarters are in Lund, Sweden. The company also has subsidiaries Jupiter, Fl, USA, and Toronto, ON, Canada. For more information, visit www.cellavision.com.
CellaVision's share is listed on First North at the OMX Stockholm Stock Exchange. The company's Certified Advisor is Remium AB.
For more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB